<DOC>
	<DOCNO>NCT01845025</DOCNO>
	<brief_summary>The purpose study ass whether risk serious asthma-related event ( asthma-related hospitalization , asthma related intubation , asthma related death ) adolescent adult ( 12 year age old ) take inhale formoterol fumarate/fluticasone propionate combination take inhaled fluticasone propionate alone .</brief_summary>
	<brief_title>Study Safety Foradil Patients With Persistent Asthma</brief_title>
	<detailed_description>This 26 week , double blind , randomize , active-controlled safety study Foradil free combination inhale corticosteroid versus inhale corticosteroid alone adults adolescent patient persistent asthma . The primary objective study demonstrate addition formoterol fumarate fluticasone propionate non-inferior fluticasone propionate alone term risk composite serious asthma related event ( asthma-related hospitalization , asthma-related intubation , asthma-related death ) . The individual component composite primary endpoint ( i.e. , asthma-related hospitalization , asthma-related intubation asthma-related death ) assess secondary safety endpoint . The efficacy assessment secondary objective .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Key 1 . Written informed consent , assent applicable , must obtain assessment perform . 2 . Male female patient 12 year age old 3 . Confirmed diagnosis persistent asthma , define national international asthma guideline ( e.g. , GINA ; NIH ; etc . ) least 1 year prior study enrollment . 4 . PEF≥50 % predict normal value . 5 . Current appropriate use one treatment list protocol asthma . 6 . Recent asthma exacerbation 30 day 12 month prior randomization either : require treatment systemic corticosteroid ( tablet , suspension , injection ) require hospitalization ( defined inpatient stay &gt; 24hour stay observation area emergency room equivalent facility ) Key 1 . History lifethreatening asthma episode require intubation and/or associate hypercapnia require noninvasive ventilatory support . 2 . Current evidence pneumonia , pneumothorax , atelectasis , pulmonary fibrotic disease , allergic bronchopulmonary aspergillosis , cystic fibrosis , bronchopulmonary dysplasia , respiratory abnormality asthma . 3 . Current evidence , past physician assessment , chronic bronchitis , emphysema , chronic obstructive pulmonary disease . 4 . History smoke ≥ 10 pack year . 5 . Exercise induced asthma ( asthmarelated diagnosis ) require daily asthma control medicine . 6 . Suspected documented bacterial viral infection upper low respiratory tract , sinus middle ear resolve randomization . 7 . Worsening/Unstable asthma within 7 day prior randomization . 8 . Any asthma exacerbation require systemic corticosteroid within 30 day randomization 4 separate exacerbation 12 month precede randomization . 9 . Two hospitalization great 24 hour duration treatment asthma 12 month precede randomization . 10 . History hypersensitivity beta2agonist , sympathomimetic drug , inhaled corticosteroid , systemic corticosteroid therapy component possible study treatment trial , include severe milk protein hypersensitivity . 11 . Use antiIgE ( e.g. , omalizumab ) monoclonal antibody , 6 month prior randomization . 12 . Use ( Beta ) βblockers within 1 day prior first dose study medication . 13 . Use ICS , LABA , ICS+LABA , LTRAs , leukotriene modifier , anticholinergic , theophylline must discontinue prior first dose investigational treatment . 14 . Use potent CYP3A4 inhibitor within 4 week randomization ( e.g. , ritonavir , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , saquinavir , ketoconazole , telithromycin ) .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Asthma</keyword>
	<keyword>formoterol fumarate</keyword>
	<keyword>Foradil</keyword>
	<keyword>inhale corticosteroid</keyword>
	<keyword>fluticasone propionate</keyword>
	<keyword>safety</keyword>
</DOC>